• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by BrainsWay Ltd.

    6/11/25 7:30:06 AM ET
    $BWAY
    Medical/Dental Instruments
    Health Care
    Get the next $BWAY alert in real time by email
    6-K 1 f6k_061025.htm FORM 6-K
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 6-K

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

    For the month of June 2025

    Commission File Number: 001-35165

    BRAINSWAY LTD.
    (Translation of registrant's name into English)

    16 Hartum Street RAD Tower, 14th Floor
    Har HaHotzvim
    Jerusalem, 9777516, Israel
    (+972-2) 582-4030
     (Address and telephone number of Registrant’s principal executive office)

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
    Form 20-F [ X ]      Form 40-F [   ]

    This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 22, 2019 (Registration No. 333- 230979) and the Company's Registration Statements on Form F-3 filed with the Securities and Exchange Commission on July 22, 2024 (Registration No. 333-280934) and on April 22, 2025 (Registration No. 333-286672).


    EXHIBIT INDEX

     

    Exhibit Number Description
      
    99.1 Press Release dated June 11, 2025
     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

          BRAINSWAY LTD.    
      (Registrant)
       
      
    Date: June 11, 2025     /s/ Hadar Levy     
      Hadar Levy
      Chief Executive Officer
      

     

    Get the next $BWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BWAY

    DatePrice TargetRatingAnalyst
    11/16/2023Outperform → Mkt Perform
    Raymond James
    3/3/2022$15.00Buy
    Loop Capital
    11/29/2021$14.00 → $15.00Buy
    HC Wainwright & Co.
    8/12/2021$17.00 → $14.00Buy
    HC Wainwright & Co.
    7/19/2021$17.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BWAY
    SEC Filings

    See more
    • SEC Form 6-K filed by BrainsWay Ltd.

      6-K - Brainsway Ltd. (0001505065) (Filer)

      6/11/25 7:30:06 AM ET
      $BWAY
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by BrainsWay Ltd.

      6-K - Brainsway Ltd. (0001505065) (Filer)

      6/4/25 7:30:04 AM ET
      $BWAY
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by BrainsWay Ltd.

      6-K - Brainsway Ltd. (0001505065) (Filer)

      5/13/25 7:30:06 AM ET
      $BWAY
      Medical/Dental Instruments
      Health Care